Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
miércoles, octubre 21
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Tyra Biosciences Inc
TYRA
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$20.47
1.13
5.84%
Últ. Act.: Oct 20, 5:00 PM
$20.47
1.13
5.84%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Privacy Manager
Tyra Biosciences Financials
Tyra Biosciences (TYRA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Stock Market Today: S&P 500, Dow and Nasdaq Futures Fall as Brent Hovers Near $107 and FOMC Commences Two-Day Meeting— MSTR, CRWD, BMM in Focus (UPDATED)
U.S. stock futures declined on Tuesday, as the Dow Jones, S&P 500 and Nasdaq 100 indices fell, following Monday's lower close.
Rishabh Mishra
Crude Oil Jumps 3%; Corning Shares Move Lower
U.S. stocks fell Monday as tech slid; Nvidia may invest $10B in Anthropic’s IPO. Oil rose 3%, while gold, silver and copper declined.
Avi Kapoor
PRO
Tyra Biosciences Q2 EPS $(0.69) Misses $(0.65) Estimate
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.65) by 6.15 percent. This is a 46.81 percent decrease over losses of $(0.47) per share
Benzinga Newsdesk
PRO
Tyra Biosciences Q1 EPS $(0.64) Misses $(0.59) Estimate
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.59) by 8.47 percent. This is a 36.17 percent decrease over losses of $(0.47) per share from
Benzinga Newsdesk
PRO
Tyra Biosciences Q4 EPS $(0.57) Misses $(0.55) Estimate
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.55) by 4.2 percent. This is a 32.56 percent decrease over losses of $(0.43) per share from
Benzinga Newsdesk
PRO
Tyra Biosciences Q3 EPS $(0.50), Inline
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.50) per share which met the analyst consensus estimate. This is a 21.95 percent decrease over losses of $(0.41) per share from the same period last year.
Benzinga Newsdesk
